0000950170-24-038822.txt : 20240329
0000950170-24-038822.hdr.sgml : 20240329
20240329215507
ACCESSION NUMBER: 0000950170-24-038822
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20221115
FILED AS OF DATE: 20240329
DATE AS OF CHANGE: 20240329
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: TREACE JAMES T
CENTRAL INDEX KEY: 0001185191
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40355
FILM NUMBER: 24805324
MAIL ADDRESS:
STREET 1: 117 BRISTOL PLACE
CITY: PONTE VEDRA BEACH
STATE: FL
ZIP: 32082
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: TREACE MEDICAL CONCEPTS, INC.
CENTRAL INDEX KEY: 0001630627
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
ORGANIZATION NAME: 08 Industrial Applications and Services
IRS NUMBER: 471052611
STATE OF INCORPORATION: FL
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 100 PALMETTO PARK PLACE
CITY: PONTE VEDRA
STATE: FL
ZIP: 32081
BUSINESS PHONE: (904) 373-5940
MAIL ADDRESS:
STREET 1: 100 PALMETTO PARK PLACE
CITY: PONTE VEDRA
STATE: FL
ZIP: 32081
4
1
ownership.xml
4
X0508
4
2022-11-15
false
0001630627
TREACE MEDICAL CONCEPTS, INC.
TMCI
0001185191
TREACE JAMES T
C/O TREACE MEDICAL CONCEPTS, INC.
100 PALMETTO PARK PLACE
PONTE VEDRA
FL
32081
true
false
false
false
true
Common Stock
2022-11-15
4
S
false
46500
20.1200
D
1039941
D
Common Stock
2022-11-15
4
S
false
1600
21.1813
D
1038341
D
Common Stock
2022-11-15
4
S
false
200
21.9700
D
1038141
D
Common Stock
2022-11-15
4
S
false
1700
24.0167
D
1036441
D
Common Stock
556183
I
By Spouse
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $19.55 to $20.4600 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $20.6200 to $21.5400 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $23.6100 to $24.6000 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
/s/ Lisa O. Taylor as Attorney in Fact for James Treace
2024-03-29